WHO Issues Concern Over Critical Scarcity of Weight-Loss Injections
Under a tenth of patients that would benefit from weight-loss injections such as Wegovy are able to get them, warns the WHO as it publishes its inaugural recommendations on the drugs.
Considering in excess of 1,000,000,000 individuals worldwide now obese, it is advocating for broader and more equitable access to these injectable treatments.
Based on estimates, in excess of 2,000,000,000 could be living with obesity by 2030 if no action is taken.
"The latest guidelines affirms that excess weight is a lifelong illness that can be treated with holistic and continuous treatment," said WHO director-general Tedros Adhanom Ghebreyesus.
High costs, limited production capacity, and distribution challenges are key obstacles to broad access to the injections that can help people shift substantial weight, notes the organization.
Skinny Jab Shortage
Despite the present best projected scenario, the production of such drugs could only cover about 100 million people – under 10% of those who need them, according to the WHO.
The guideline urges nations and manufacturers to increase access, through strategies including patent sharing.
The intellectual property rights on the active ingredient – the main component of Novo Nordisk's Wegovy – is set to lapse in a number of countries in 2026.
How Obesity Injections Operate
GLP-1 drugs imitate a biological compound to delay gastric emptying, reduce hunger and increase the sense of being full so users consume fewer calories.
Patients commonly see weight reduction after several weeks of beginning the once-weekly jabs.
Evidence points to users may put most of the weight back on within a year of discontinuing the drug, as their typical appetite resume.
To be above a healthy weight elevates your likelihood for experiencing medical conditions, including diabetes, heart disease, brain attack, and specific malignancies.
Excess weight concerns people in countries worldwide and was associated with 3.7 million deaths worldwide in 2024, according to the WHO.
